Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting

Piccinni, Carlo, Motola, Domenico, Marchesini, Giulio, Poluzzi, Elisabetta·2011·Diabetes Care

DOI 10.2337/dc10-2412

Cited by (239)

Items 101–200 of 239

Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
Jessica Katharine Dyson, Quentin Mark Anstee, Stuart McPherson · 2015 · Postgraduate Medical Journal
Why We Need an Efficient and Careful Pharmacovigilance?
Rita Businaro · 2013 · Journal of Pharmacovigilance
PPAR Medicines and Human Disease: The ABCs of It All
Anthony J. Apostoli, Christopher J.B. Nicol · 2012 · PPAR Research
Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse Events
Kejian Wang, Mei Wan, Rui‐Sheng Wang, Zuquan Weng · 2016 · Journal of Medical Internet Research
Association between Concomitant Use of Acyclovir or Valacyclovir with NSAIDs and an Increased Risk of Acute Kidney Injury: Data Mining of FDA Adverse Event Reporting System
Zhihua Yue, Jinhai Shi, Haona Li, Huiyi Li · 2017 · Biological and Pharmaceutical Bulletin
Beyond Metformin: Initiating Combination Therapy in Patients with Type 2 Diabetes Mellitus
Jennifer D. Goldman · 2011 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Pioglitazone: an agent which reduces stroke, myocardial infarction and death and is also a key component of the modern paradigm for the optimum management of type 2 diabetes
Robert E. J. Ryder · 2011 · The British Journal of Diabetes
Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome
Simona Moscatiello, Raffaella Di Luzio, Anna Simona Sasdelli, Giulio Marchesini · 2011 · Expert Opinion on Pharmacotherapy
The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH)
Eiji Kakazu, Yasuteru Kondo, Masashi Ninomiya, Osamu Sandes Kimura, Futoshi Nagasaki, Yoshiyuki Ueno, Tooru Shimosegawa · 2012 · Hepatology International
Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.
Gangfeng Wu, Xiaolong Zhang, Zhengang Luo, Jiajun Yan, Shouhua Pan, Xiangrong Ying, Jiangang Pan, Guan-Fu Zhang · 2015 · Europe PMC (PubMed Central)
The Effects of 6 Common Antidiabetic Drugs on Anti-PD1 Immune Checkpoint Inhibitor in Tumor Treatment
Zetao Zhan, Lu Liu, Mingzhen Cheng, Yi Gao, Weijie Zhou · 2022 · Journal of Immunology Research
Cardiovascular thromboembolic events associated with febuxostat: Investigation of cases from the FDA adverse event reporting system database
Pranav Gandhi, William M. Gentry, Michael B. Bottorff · 2013 · Seminars in Arthritis and Rheumatism
Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
Shaoling Yang, Jijiao Wang, Ming Chen, Lu Xu, Nan Li, Yili Luo, Le Bu, Manna Zhang, Hong Li, Benli Su · 2018 · International Journal of Medical Sciences
Implications of Off‐Target Serotoninergic Drug Activity: An Analysis of Serotonin Syndrome Reports Using a Systematic Bioinformatics Approach
Vaughn L. Culbertson, Shaikh Emdadur Rahman, Grayson C. Bosen, Matthew L. Caylor, Megan M. Echevarria, Dong Qing Xu · 2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Assessing Pancreatic Cancer Risk Associated with Dipeptidyl Peptidase 4 Inhibitors: Data Mining of FDA Adverse Event Reporting System (FAERS)
Xiaodong Feng Amie Cai · 2013 · Journal of Pharmacovigilance
Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
Yubi Lin, Siqi He, Ruiling Feng, Zhe Xu, Wanqun Chen, Zifeng Huang, Yang Liu, Qianhuan Zhang, Bin Zhang, Kejian Wang et al. · 2017 · Oncotarget
Idealized PPAR-Based Therapies: Lessons from Bench and Bedside
Angélica Amorim Amato, Francisco de Assis Rocha Neves · 2012 · PPAR Research
Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic.
Marialena Mouzaki, Johane P. Allard · 2012 · Europe PMC (PubMed Central)
Effect of statins on blood pressure: Analysis on adverse events released by FDA
Tao You, Xingguang Liu, Xiao-dong Hou, Xin-kuan Wang, Han-hui Xie, Fan Ding, Yi Kang, Peng Zhang, Xiaodong Xie · 2017 · Clinical and Experimental Hypertension
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
Esther Phielix E, A. Brehm, Elisabeth Bernroider, Martin Krššák, Christian Heinz Anderwald, Michael Krebs, Albrecht Ingo Schmid, P. Nowotny, Michael Roden · 2013 · Diabetes Obesity and Metabolism
Metabolic Surgery for Type 2 Diabetes in Patients with a BMI of <35 kg/m2: A Surgeon’s Perspective
RICARDO VITOR COHEN, Pedro Paulo de Paris Caravatto, Tarissa Beatrice Zanata Petry · 2013 · Obesity Surgery
Pioglitazone and the risk of bladder cancer
Dominique Hillaire‐Buys, Jean‐Luc Faillie · 2012 · BMJ
Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia
Roger S. Ho · 2020 · JAMA Dermatology
High Glucose with Insulin Induces Cell Cycle Progression and Activation of Oncogenic Signaling of Bladder Epithelial Cells Cotreated with Metformin and Pioglitazone
Daejin Kim, Byul‐Nim Ahn, Yeong Seok Kim, Dae Young Hur, Jae Wook Yang, Ga Bin Park, Jung Eun Jang, Eun Ju Lee, Min Jeong Kwon, Tae Nyun Kim et al. · 2019 · Journal of Diabetes Research
Current and Emerging Strategies in Bladder Cancer
Simone Carradori, Cristiano Vincenzo Emilio Cristini, Daniela Secci, Caterina Gulìa, Vincenzo Gentile, Giovanni Battista Di Pierro · 2012 · Anti-Cancer Agents in Medicinal Chemistry
Pioglitazone—Do we really need it to manage type 2 diabetes?
Binayak Sinha, Samit Ghosal · 2013 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Spirulina Reverses Histomorphological Changes in Diabetic Osteoporosis in Pioglitazone Treated Rats
Chauhan Devesh · 2012 · Journal of Diabetes & Metabolism
Screening for Adiponectin Secretion Regulators
Kyosuke Hino, Hidetaka Nagata · 2012 · Vitamins and hormones
Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ –Retinoid X Receptor α Coactivator
Tali Shalom‐Barak, Jaclyn Liersemann, Babak Memari, Lawrence Flechner, Caitlin E. Devor, Tiffany M. Bernardo, Suyeon Kim, Nobuyuki Matsumoto, Scott L. Friedman, Ronald M. Evans et al. · 2018 · Molecular and Cellular Biology
Cardiac failure in patients treated with azacitidine, a pyrimidine analogue: Case reports and disproportionality analyses in Vigibase
Justine Perino, Nathan Mottal, Yohann Bohbot, V. Servant, Aude Berroneau, Pierre Poustis, Pierre Fenaux, Kamel Laribi, Aude Charbonnier, Emilien Bilion et al. · 2020 · British Journal of Clinical Pharmacology
Chemopreventive drugs: Mechanismsviainhibition of cancer stem cells in colorectal cancer
Tae Il Kim · 2014 · World Journal of Gastroenterology
Pneumothorax as an Adverse Drug Event: An Exploratory Aggregate Analysis of the US FDA AERS Database Including A Confounding By Indication Analysis Inspired by Cornfield's Condition
Manfred Hauben, Eric Y. Hung · 2013 · International Journal of Medical Sciences
Dabigatran–dronedarone interaction in a spontaneous reporting system
Pranav Gandhi, William M. Gentry, Michael B. Bottorff · 2013 · Journal of the American Pharmacists Association
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy
Priscilla A. Hollander, Danny H. Sugimoto, Aleksandra Vlajnic, Charles Kilo · 2015 · Journal of Diabetes and its Complications
Association Between Pioglitazone and Urothelial Bladder Cancer
Yanina Barbalat, Viktor Y. Dombrovskiy, Robert E. Weiss · 2012 · Urology
Study design choices for evaluating the comparative safety of diabetes medications: An evaluation of pioglitazone use and risk of bladder cancer in older US adults with type‐2 diabetes
Elizabeth M. Garry, John B. Buse, Mugdha Gokhale, Jennifer Leigh Lund, Matthew E. Nielsen, Virginia Pate, Til Stürmer‎ · 2019 · Diabetes Obesity and Metabolism
Pioglitazone, Bladder Cancer, and the Presumption of Innocence
Georgios S. Papaetis · 2022 · Current Drug Safety
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia
Dong Qing Xu, Alexandrea G. Ham, Rick D. Tivis, Matthew L. Caylor, Aoxiang Tao, Steve T. Flynn, Peter J. Economen, Hung K. Dang, Royal W. Johnson, Vaughn L. Culbertson · 2017 · EBioMedicine
Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature
Rainer Winnenburg, Nigam Haresh Shah · 2016 · BMC Bioinformatics
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System
Ippazio Cosimo Antonazzo, Emanuel Raschi, Emanuele Forcesi, Trond Riise, Kjetil Bjørnevik, Elisa Baldin, Fabrizio De Ponti, Elisabetta Poluzzi · 2018 · Expert Opinion on Drug Safety
Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications
Hua-Fen Chen, Shwe-Winn Chen, Ya‐Hui Chang, Chung‐Yi Li · 2015 · Medicine
Effects of pioglitazone on cardiac ion currents and action potential morphology in canine ventricular myocytes
Kornél Kistamás, Norbert Szentandrássy, Bence Hegyi, Ferenc Ruzsnavszky, Krisztina Váczi, László Bárándi, Balázs Horváth, Andrea Szebeni, János Magyar, Tamás Bányász et al. · 2013 · European Journal of Pharmacology
Hypoglycaemia in elderly patients with type 2 diabetes mellitus: a review of risk factors, consequences and prevention
Badieh Jafari, Mary E Britton · 2015 · Journal of Pharmacy Practice and Research
Worsening of myasthenia due to antiepileptic, antipsychotic, antidepressant, and sedative medication: An estimation of risk based on reporting frequency
Peter Trillenberg, Alexander Katalinic, Klaus Junghanns, Julia Thern · 2021 · European Journal of Neurology
Exposure of Drugs for Hypertension, Diabetes, and Autoimmune Disease During Pregnancy and Perinatal Outcomes
Ryosuke Sato, Mutsuhiro Ikuma, Kazunori Takagi, Yoshiaki Yamagishi, Junichi Asano, Yusuke Matsunaga, Hiroshi Watanabe · 2015 · Medicine
Identification of Suicide-Related Events Through Network Analysis of Adverse Event Reports
Alwis Nazir, Takashi Ichinomiya, Nobuteru Miyamura, Yasuaki Sekiya, Yasutomi Kinosada · 2014 · Drug Safety
Treatment of Type 2 Diabetes Mellitus in the Older Adult: A Review
Richard E. Pratley, Simon R. Heller, Mary Alice Miller · 2014 · Endocrine Practice
Trends in the incidence of use of noninsulin glucose‐lowering drugs between 2006 and 2013 in France
M Arnaud, Julien Bezin, Bernard Bégaud, Antoine Pariente, Francesco Salvo · 2017 · Fundamental and Clinical Pharmacology
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10‐month withdrawal of pioglitazone in patients with Type 2 diabetes
Kun‐Der Lin, Minyoung Lee, C.‐C. Feng, Brian Chen, Ming‐Lung Yu, Sung Jae Shin · 2014 · Diabetic Medicine
Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus
Kazuya Fujihara, Hirohito Sone · 2018 · Annals of Vascular Diseases
Diabetes therapy‐focus on Asia: second‐line therapy debate: insulin/secretagogues
Roy Eldor, Itamar Raz · 2012 · Diabetes/Metabolism Research and Reviews
Pioglitazone--where do we stand in India?
Viswanathan Mohan, Sharad Bedi, Ranjit Unnikrishnan I, Binode Kumar Sahay, Shashank Joshpi, Anoop Misra · 2012 · PubMed
Diabetes and cancer: Could vitamin D provide the link?
Shahzaib Ahmad, Tahseen Ahmad Chowdhury, Barbara Joan Boucher · 2012 · Journal of Diabetes and its Complications
Use of an entacapone-containing drug combination and risk of death: Analysis of the FDA AERS (FAERS) database
Thamir M. Alshammari, Eman N. AlMutairi · 2014 · Saudi Pharmaceutical Journal
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
Luca Montesi, Arianna Mazzotti, Simona Moscatiello, Gabriele Forlani, Giulio Marchesini · 2013 · Hepatology International
Diabetes medications and cancer risk: review of the literature.
Quang Phuong Huynh Nguyen, Lindsay Sanders, Anu P Michael, Scott R. Anderson, Loida D Nguyen, Zackary A. Johnson · 2012 · PubMed Central
Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue
Jean‐Luc Faillie, Dominique Hillaire‐Buys · 2015 · Pharmacoepidemiology and Drug Safety
Systematic Reviews to Ascertain the Safety of Diabetes Medications
Michael R. Gionfriddo, Oscar L. Morey‐Vargas, Juan Pablo Brito, Aaron L. Leppin, Mohammad Hassan Murad, Víctor M. Montori · 2014 · Current Diabetes Reports
Carbohydrate Metabolism in Kidney Disease and Kidney Failure
Eberhard Ritz, Marcin Adamczak, Andrzej Więcek · 2012 · Elsevier eBooks
Safety Profile of Monoclonal Antibody Compared With Traditional Anticancer Drugs: An Analysis of Henan Province Spontaneous Reporting System Database
Zhiming Jiao, Ganyi Wang, Zhanchun Feng, Ziqi Yan, Jinwen Zhang, Gang Li, Qianyu Wang, Da Feng · 2022 · Frontiers in Pharmacology
Anti- and Protumorigenic Effects of PPARγin Lung Cancer Progression: A Double-Edged Sword
Howard Y. Li, Mary C.M. Weiser‐Evans, Raphael A. Nemenoff · 2012 · PPAR Research
Diabetes, diabetes therapies and cancer: what’s the link?
Jason Seewoodhary, Stephen Charles Bain · 2011 · The British Journal of Diabetes
Pioglitazone and bladder cancer: the pros and cons.
Vijay Panikar · 2012 · PubMed
Toxicological evaluation of subchronic use of pioglitazone in mice.
Said Said Elshama, Ayman El-Meghawry El-Kenawy, Hosam-Eldin Hussein Osman · 2016 · PubMed Central
Assessment of suspected adverse drug reactions in elderly patients with diabetes mellitus based on a Portuguese spontaneous reporting database: analysis of reporting from 2008 to 2018
Cristina Sofia de Jesus Monteiro, Samuel Silvestre, Ana Paula Duarte, Gilberto Alves · 2021 · Expert Opinion on Drug Safety
Fibrates and Risk of Cancer in Tissues with High PPAR-α Concentration: A Nested Case–Control Study
Francesco Salvo, Fabienne Bazin, Aude Kostrzewa, Christian Bandre, Philip Robinson, Nicholas D Moore, Bernard Bégaud, Antoine Pariente · 2014 · Drug Safety
Reassessment of pioglitazone and bladder cancer based on FAERS database
Hai-Yan Chen, Hui Zhao, Junjie Yang, Qian Zhang, Ming-Ming Yan, Xiaoyan Qiu · 2024 · Expert Opinion on Drug Safety
Cancer biology in diabetes update: Focusing on antidiabetic drugs
Emi Kawakita, Keizo Kanasaki · 2024 · Journal of Diabetes Investigation
Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?
Eleonore Fröhlich, Richard Wahl · 2011 · Diabetes Obesity and Metabolism
Juvenile oral angiofibroma in a female.
B K Reddy, V Isaac, Manmath Nayak, S R Prabhu · 1979 · PubMed
Mutations in gliclazide‐associated genes may predict poor bladder cancer prognosis
Weiheng Wen, Jinru Gong, Peili Wu, Min Zhao, Ming Wang, Hong Chen, Jia Man Sun · 2018 · FEBS Open Bio
Large Clinical Trials and Registries—Clinical Research Institutes
Robert M. Califf · 2017 · Elsevier eBooks
The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016
Sarah Ann Townsend, Philip Noel Newsome · 2017 · Digestive Diseases
Skin cancer signal associated with phosphodiesterase inhibitors: gaining insight through the FDA pharmacovigilance database
Junwei Chow, Ming‐Ming Yan, Hui Zhao, Ziran Li, Qian Zhang, Mingkang Zhong, Xiaoyan Qiu · 2022 · Expert Opinion on Drug Safety
COMPARISON OF THE EFFECT OF PTEROCARPUS MARSUPIUM WITH PIOGLITAZONE IN DEXAMETHASONE-INDUCED INSULIN RESISTANCE
Narendar Koyagura, Nagendra Nayak Im, M G Jamadar, Ashok M Patil, Sanjit Anand · 2016 · Asian Journal of Pharmaceutical and Clinical Research
Role of Physiotherapy in Managing Type 2 Diabetes Mellitus
Navjot Kaur, Sandeep Kumar Singh · 2022 · Journal of Diabetology
Long-term surveillance of the anti-amyloid monoclonal antibody lecanemab: rights and duties of pharmacovigilance
Monia Donati, Angela Boccia, Fabrizio De Ponti, Elisabetta Poluzzi, Emanuel Raschi · 2025 · Alzheimer s Research & Therapy
Assessing Risks of Impaired Healing and Osteomyelitis Associated with Bisphosphonates Using FDA Adverse Event Reporting System (FAERS)
Xiaodong Feng, Amie Cai · 2015 · Journal of Pharmacovigilance
Advances in the prevention, diagnosis and therapy of vascular diseases
Katalin Szabó, Róza Ádány, József Balla, Zoltán Balogh, Zoltan Boda, Istvan Ferenc Edes, István Fekete, Miklós Káplár, János Mátyus, László Oláh et al. · 2012 · Orvosi Hetilap
Cardiometabolic interventions – focus on transcriptional regulators
Joshua T. Chai, Robin P. Choudhury · 2013 · European Journal of Cardiovascular Medicine
Applied Data Mining of the FDA Adverse Event Reporting System, FAERS, and the Japanese Adverse Drug Event Report Database, JADER: Signal Detection of Adverse Events by New Quinolones
Kouichi Hosomi, Mari Arai, Mai Fujimoto, Mitsutaka Takada · 2015 · Iyakuhin Johogaku
Pharmacological and Toxicological Advances in PPAR-Related Medicines
Yuji Kamijo, Christopher J.B. Nicol, Stefan E.H. Alexson · 2012 · PPAR Research
Comment on: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”
Emanuel Raschi, Elisabetta Poluzzi, Fabrizio De Ponti · 2015 · Clinical Pharmacokinetics
Acarbose revisited for efficacy, safety and cardiovascular benefits: a key role for controlling glycemic variability
Markolf Hanefeld E · 2012 · Expert Review of Endocrinology & Metabolism
Drugs and Cancer: an Analysis of the French Pharmacovigilance Database
Geneviève Durrieu, Benjamin Mazau, Jérémie Jegu, Maryse Lapeyre‐Mestre, Jean‐Pierre Delord, Jean‐Louis Montastruc · 2013 · Therapies
Los nuevos antidiabéticos en el punto de mira… ¿razones de seguridad o caza de brujas?
Joana Nicolau, Lluís Masmiquel · 2011 · Endocrinología y Nutrición
Pioglitazone: How Pharmacology Can be used Interchangeably with Mammonology in the Developing Countries?
Mina Thabet Kelleni · 2014 · Journal of Diabetes & Metabolism
Translational Endocrinology & Metabolism: Metabolic Surgery Update
DEL PRATO, STEFANO, Lebovitz HE · 2012 · Translational endocrinology & metabolism
The Role of Pioglitazone Against Ehrlich Solid Carcinoma Mice Model Through Antiproliferative and Antiangiogenic Pathways
Dalia K. Zaafar, Heba M. A. Khalil, Soha Osama Hassanin, Mohamed R. Mousa, Mona G. Khalil · 2023 · Advances in Animal and Veterinary Sciences
The new antidiabetic agents in the firing line… safety reasons or witch hunt?
Joana Nicolau, Lluís Masmiquel · 2012 · Endocrinología y Nutrición (English Edition)
Pioglitazone Induced Carcinoma of Urinary Bladder: A Case Report
Unmesh Vidyadhar Takalkar, Shilpa Balaji Asegaonkar, Suresh Hariram Advani · 2013 · HAL
Controversies of Pioglitazone in the Management of Diabetes Mellitus
T. Balasubramanian, M Karthikeyan, Sujith Puthanpurakkal · 2016
Multifaceted Antipathogenic Activity of Two Novel Natural Products, Chermesiterpenoid B and Chermesiterpenoid B Seco Acid Methyl Ester, Against Pseudomonas aeruginosa
Dan-Dan Li, Ying Wang, Huiyan Li, Wen‐Xin Niu, Jongki Hong, Jee Hyung Jung, Joonhee Lee · 2025 · Microbial Biotechnology
Health implications of prediabetes and the role of trace elements in insulin resistance
Hanan Mohamed Amer, Sherihan Aboelyazed, Farida Elshafeey, Salah Hussein Elhalawany · 2025 · Future Journal of Pharmaceutical Sciences
Will PPAR-γ agonist therapy still have a role in diabetes management in 2013?
George Grunberger · 2012 · Diabetes Management
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes
Sang‐Man Jin, Bae Jun Oh, Suel Lee, Jung Mook Choi, Soo Jin Yang, Sung Woo Park, Kwang‐Won Kim, Jae Hyeon Kim, Cheol‐Young Park · 2013 · Yonsei Medical Journal
What the primary healthcare worker needs to know about the management of type 2 diabetes
W.F. Mollentze · 2012 · South African Family Practice
Use of noninsulin anti diabetics for prevention and treatment of cancer- narrative review article.
Sadaf Raana, Aqeel Javeed · 2015 · PubMed Central
Obesity, Type 2 Diabetes and Cancer
Rosalyn Dolores Ferguson, Derek LeRoith · 2011 · Springer eBooks
Emerging Link between Diabetes and Cancer
Hiroshi Noto, Atsushi Goto, Tetsuro Tsujimoto, Mitsuhiko Noda · 2015 · Journal of General and Family Medicine